Akamis Bio is a clinical-stage oncology company.
Akamis Bio has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
Akamis Bio's investors include Invesco, SR One, ARCH Venture Partners, Bristol-Myers Squibb, Salica.
Akamis Bio is headquartered in Abingdon, United Kingdom.
Akamis Bio is a clinical-stage oncology company.
Akamis Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akamis Bio — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/akamis-bio. Accessed October 22, 2026.
VCBacked. (2024). Akamis Bio — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/akamis-bio
{{cite web |title=Akamis Bio — Funding & Investors |url=https://www.vcbacked.co/company/akamis-bio |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated